Japan's Takeda to buy U.S. cancer drug maker Ariad in $5.2 bln deal
Jan 9 (Reuters) - Japan's Takeda Pharmaceutical Co Ltd said on Monday it would acquire cancer drug maker Ariad Pharmaceuticals Inc in a deal valued at $5.20 billion. [Source]
Publication Date:Origin: reuters.com
Category: mergersNews
Topics: maker, cancer, Takeda, Japan's, billion, valued, Ariad Pharmaceuticals, acquire, would, Pharmaceutical, (Reuters), Ariad